Detalhe da pesquisa
1.
Multi-omic machine learning predictor of breast cancer therapy response.
Nature
; 601(7894): 623-629, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875674
2.
Optimising the diagnostic accuracy of First post-contrAst SubtracTed breast MRI (FAST MRI) through interpretation-training: a multicentre e-learning study, mapping the learning curve of NHS Breast Screening Programme (NHSBSP) mammogram readers using an enriched dataset.
Breast Cancer Res
; 26(1): 85, 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38807211
3.
Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite study.
Histopathology
; 84(5): 847-862, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38233108
4.
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol
; 23(1): 149-160, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902335
5.
Evaluating the effectiveness of abbreviated breast MRI (abMRI) interpretation training for mammogram readers: a multi-centre study assessing diagnostic performance, using an enriched dataset.
Breast Cancer Res
; 24(1): 55, 2022 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35907862
6.
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.
Br J Haematol
; 192(6): 997-1005, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798327
7.
A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients.
Breast Cancer Res Treat
; 185(2): 433-440, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025481
8.
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
Lancet
; 393(10166): 51-60, 2019 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30449623
9.
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Lancet
; 393(10191): 2599-2612, 2019 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31178152
10.
Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone.
Radiology
; 297(3): 622-629, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078998
11.
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet Oncol
; 20(12): 1760-1772, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31668592
12.
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.
N Engl J Med
; 374(15): 1444-54, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27007578
13.
25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial.
Br J Cancer
; 119(7): 793-800, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30033445
14.
Double Reading in Breast Cancer Screening: Cohort Evaluation in the CO-OPS Trial.
Radiology
; 287(3): 749-757, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29634439
15.
Adjuvant trastuzumab duration trials in HER2 positive breast cancer - what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results.
BMC Cancer
; 18(1): 391, 2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29621991
16.
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial.
Lancet Oncol
; 18(6): 755-769, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28479233
17.
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.
Mod Pathol
; 30(8): 1069-1077, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28548129
18.
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial.
Value Health
; 20(10): 1311-1318, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29241890
19.
A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines.
BMC Med Res Methodol
; 17(1): 108, 2017 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28720094
20.
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.
Breast Cancer Res
; 18(1): 21, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26882907